JP2020531487A5 - - Google Patents

Download PDF

Info

Publication number
JP2020531487A5
JP2020531487A5 JP2020510099A JP2020510099A JP2020531487A5 JP 2020531487 A5 JP2020531487 A5 JP 2020531487A5 JP 2020510099 A JP2020510099 A JP 2020510099A JP 2020510099 A JP2020510099 A JP 2020510099A JP 2020531487 A5 JP2020531487 A5 JP 2020531487A5
Authority
JP
Japan
Prior art keywords
pyridine
pharmaceutically acceptable
pyrrolo
trifluoromethyl
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020510099A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020531487A (ja
JP7199738B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2018/072785 external-priority patent/WO2019038384A1/en
Publication of JP2020531487A publication Critical patent/JP2020531487A/ja
Publication of JP2020531487A5 publication Critical patent/JP2020531487A5/ja
Priority to JP2022198545A priority Critical patent/JP2023021277A/ja
Application granted granted Critical
Publication of JP7199738B2 publication Critical patent/JP7199738B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020510099A 2017-08-23 2018-08-23 アザインドリルピリドンおよびジアザインドリルピリドン化合物 Active JP7199738B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022198545A JP2023021277A (ja) 2017-08-23 2022-12-13 アザインドリルピリドンおよびジアザインドリルピリドン化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17187519.8 2017-08-23
EP17187519 2017-08-23
PCT/EP2018/072785 WO2019038384A1 (en) 2017-08-23 2018-08-23 AZAINDOLYLPYRIDONE AND DIAZAINDOLYLPYRIDONE COMPOUNDS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022198545A Division JP2023021277A (ja) 2017-08-23 2022-12-13 アザインドリルピリドンおよびジアザインドリルピリドン化合物

Publications (3)

Publication Number Publication Date
JP2020531487A JP2020531487A (ja) 2020-11-05
JP2020531487A5 true JP2020531487A5 (enExample) 2022-10-20
JP7199738B2 JP7199738B2 (ja) 2023-01-06

Family

ID=59686871

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020510099A Active JP7199738B2 (ja) 2017-08-23 2018-08-23 アザインドリルピリドンおよびジアザインドリルピリドン化合物
JP2022198545A Ceased JP2023021277A (ja) 2017-08-23 2022-12-13 アザインドリルピリドンおよびジアザインドリルピリドン化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022198545A Ceased JP2023021277A (ja) 2017-08-23 2022-12-13 アザインドリルピリドンおよびジアザインドリルピリドン化合物

Country Status (20)

Country Link
US (2) US11498919B2 (enExample)
EP (2) EP3672967B1 (enExample)
JP (2) JP7199738B2 (enExample)
KR (1) KR102731945B1 (enExample)
CN (3) CN116589462A (enExample)
AU (1) AU2018321135B2 (enExample)
CY (1) CY1124818T1 (enExample)
DK (1) DK3672967T3 (enExample)
ES (1) ES2902346T3 (enExample)
HR (1) HRP20211999T1 (enExample)
HU (1) HUE057818T2 (enExample)
IL (3) IL302355A (enExample)
LT (1) LT3672967T (enExample)
PL (1) PL3672967T3 (enExample)
PT (1) PT3672967T (enExample)
RS (1) RS62785B1 (enExample)
SI (1) SI3672967T1 (enExample)
SM (1) SMT202100718T1 (enExample)
TW (2) TW202325708A (enExample)
WO (1) WO2019038384A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS62785B1 (sr) * 2017-08-23 2022-01-31 Sprint Bioscience Ab Jedinjenja azaindolilpiridona i diazaindolilpiridona
CN117241800A (zh) * 2020-11-25 2023-12-15 德西费拉制药有限责任公司 Vps34抑制剂的抗病毒活性
CA3199999A1 (en) 2020-11-25 2022-06-02 Deciphera Pharmaceuticals, Llc Morpholino derivatives as vsp34 inhibitors for use in the treatment of a viral infection

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1154024B (it) * 1982-09-22 1987-01-21 Lepetit Spa Derivati pridinici e procedimento per la loro produzione
KR20080016659A (ko) 2005-05-20 2008-02-21 버텍스 파마슈티칼스 인코포레이티드 단백질 키나제의 억제제로서 유용한 피롤로피리딘
CA2728559A1 (en) * 2008-07-03 2010-01-07 Exelixis Inc. Cdk modulators
CA2795422A1 (en) * 2010-04-19 2011-10-27 Abbvie Inc. Pyrrolopyridine inhibitors of kinases
KR20130130030A (ko) 2010-12-21 2013-11-29 노파르티스 아게 Vps34 억제제로서의 비-헤테로아릴 화합물
US8815853B2 (en) 2010-12-23 2014-08-26 Sanofi Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof
GB201120317D0 (en) 2011-11-24 2012-01-04 Queen Mary & Westfield College Screening method
CN103450152B (zh) 2012-06-04 2015-11-18 济南海乐医药技术开发有限公司 基于吲唑、吲哚或氮杂吲唑、氮杂吲哚的双芳基脲类结构抗肿瘤药物
FR2992314B1 (fr) 2012-06-22 2015-10-16 Sanofi Sa Nouveaux derives de 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one et 1,2,3,4-tetrahydro-pyrimido{1,2-a}pyrimidin-6-one comportant une morpholine substituee, leur preparation et leur utilisation pharmaceutique
WO2015108861A1 (en) 2014-01-14 2015-07-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2015108881A1 (en) * 2014-01-14 2015-07-23 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
MA39823A (fr) 2014-04-03 2018-01-09 Janssen Pharmaceutica Nv Dérivés de pyridine macrocyclique
MA39822A (fr) 2014-04-03 2018-02-06 Janssen Pharmaceutica Nv Dérivés de pyrimidine bicycle
DK3416945T3 (da) 2016-02-19 2020-09-21 Sprint Bioscience Ab 6-aryl-4-(morpholin-4-yl)-1h-pyridin-2-on-forbindelser anvendelige ved behandlingen af cancer og diabetes
AU2017219847B2 (en) 2016-02-19 2021-02-04 Sprint Bioscience Ab 6-heterocyclyl-4-morpholin-4-ylpyridine-2-one compounds useful for the treatment of cancer and diabetes
RS62785B1 (sr) * 2017-08-23 2022-01-31 Sprint Bioscience Ab Jedinjenja azaindolilpiridona i diazaindolilpiridona

Similar Documents

Publication Publication Date Title
JP2020531488A5 (enExample)
JP7201260B2 (ja) ピリジンアミン-ピリドンおよびピリミジンアミン-ピリドン化合物
JP6162144B2 (ja) 4,4−二置換−1,4−ジヒドロピリミジン、及びb型肝炎の処置のための医薬としてのその使用
JP2022531801A5 (enExample)
KR102525131B1 (ko) Wnt 신호 경로의 억제제로서의 N-피리디닐 아세트아미드 유도체
JP2013523884A5 (enExample)
JP2012525395A5 (enExample)
RU2018131766A (ru) 6-гетероциклил-4-морфолин-4-илпиридин-2-оны, пригодные для лечения рака и диабета
JP2019505595A5 (enExample)
JP2016513660A5 (enExample)
JP2016523911A5 (enExample)
JP2009529047A5 (enExample)
JP2016514718A5 (enExample)
JP2010513444A5 (enExample)
RU2011114487A (ru) Гетероциклические соединения как ингибиторы протеинкиназы
JP2019505594A5 (enExample)
RU2015100942A (ru) Производное пиперидинилпиразолпиридина
TW202313048A (zh) 組合療法
JP2020503302A5 (enExample)
JP2018508553A5 (enExample)
IL274198B1 (en) Use of Nox inhibitors to treat cancer
JP2023021277A5 (enExample)
JP2023021277A (ja) アザインドリルピリドンおよびジアザインドリルピリドン化合物
JP2022534434A5 (enExample)
JP2020531486A5 (enExample)